spacer
spacer

PDBsum entry 3f58

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system PDB id
3f58

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
215 a.a. *
228 a.a. *
11 a.a. *
Waters ×1
* Residue conservation analysis
PDB id:
3f58
Name: Immune system
Title: Igg1 fab fragment (58.2) complex with 12-residue cyclic peptide (including residues 315-324 of HIV-1 gp120 (mn isolate); h315s mutation
Structure: Protein (immunoglobulin gamma i (58.2)). Chain: l. Fragment: light chain of fab. Synonym: fab 58.2. Protein (immunoglobulin gamma i (58.2)). Chain: h. Fragment: heavy chain of fab. Synonym: fab 58.2. Protein (cyclic peptide (gp120)).
Source: Mus musculus. House mouse. Organism_taxid: 10090. Strain: balb/c. Synthetic: yes. Other_details: 12 residue hydrazone-linked cyclic peptide was chemically synthesized from residues 316-324 of HIV-1 gp120 strain mn.
Biol. unit: Trimer (from PQS)
Resolution:
2.80Å     R-factor:   0.200    
Authors: R.L.Stanfield,E.Cabezas,A.C.Satterthwait,E.A.Stura,A.T.Profy, I.A.Wilson
Key ref:
R.Stanfield et al. (1999). Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. Structure, 7, 131-142. PubMed id: 10368281 DOI: 10.1016/S0969-2126(99)80020-3
Date:
23-Oct-98     Release date:   09-Feb-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Struc: 215 a.a.
Protein chain
No UniProt id for this chain
Struc: 228 a.a.
Protein chain
No UniProt id for this chain
Struc: 11 a.a.
Key:    Secondary structure  CATH domain

 

 
DOI no: 10.1016/S0969-2126(99)80020-3 Structure 7:131-142 (1999)
PubMed id: 10368281  
 
 
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.
R.Stanfield, E.Cabezas, A.Satterthwait, E.Stura, A.Profy, I.Wilson.
 
  ABSTRACT  
 
BACKGROUND: The third hypervariable (V3) loop of HIV-1 gp120 has been termed the principal neutralizing determinant (PND) of the virus and is involved in many aspects of virus infectivity. The V3 loop is required for viral entry into the cell via membrane fusion and is believed to interact with cell surface chemokine receptors on T cells and macrophages. Sequence changes in V3 can affect chemokine receptor usage, and can, therefore, modulate which types of cells are infected. Antibodies raised against peptides with V3 sequences can neutralize laboratory-adapted strains of the virus and inhibit syncytia formation. Fab fragments of these neutralizing antibodies in complex with V3 loop peptides have been studied by X-ray crystallography to determine the conformation of the V3 loop. RESULTS: We have determined three crystal structures of Fab 58.2, a broadly neutralizing antibody, in complex with one linear and two cyclic peptides the amino acid sequence of which comes from the MN isolate of the gp120 V3 loop. Although the peptide conformations are very similar for the linear and cyclic forms, they differ from that seen for the identical peptide bound to a different broadly neutralizing antibody, Fab 59.1, and for a similar peptide bound to the MN-specific Fab 50.1. The conformational difference in the peptide is localized around residues Gly-Pro-Gly-Arg, which are highly conserved in different HIV-1 isolates and are predicted to adopt a type II beta turn. CONCLUSIONS: The V3 loop can adopt at least two different conformations for the highly conserved Gly-Pro-Gly-Arg sequence at the tip of the loop. Thus, the HIV-1 V3 loop has some inherent conformational flexibility that may relate to its biological function.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Stereoviews of the X-ray structures of the Fab 58.2–peptide complexes. (a) The Fab 58.2–Aib142 complex. The Cα trace is shown for the light chain (cyan) and heavy chain (blue) of the Fab. All atoms of the bound peptide are shown in red. Every tenth Cα atom is highlighted with a sphere and some atoms are labeled. (b) The Fab 58.2–His loop complex. (c) The Fab 58.2–Ser loop complex. Figures were made with the program MOLSCRIPT [74] .
 
  The above figure is reprinted by permission from Cell Press: Structure (1999, 7, 131-142) copyright 1999.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20419152 J.N.Dybowski, D.Heider, and D.Hoffmann (2010).
Prediction of co-receptor usage of HIV-1 from genotype.
  PLoS Comput Biol, 6, e1000743.  
19281264 A.Mor, E.Segal, B.Mester, B.Arshava, O.Rosen, F.X.Ding, J.Russo, A.Dafni, F.Schvartzman, T.Scherf, F.Naider, and J.Anglister (2009).
Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies.
  Biochemistry, 48, 3288-3303.  
19274732 K.L.Longenecker, Q.Ruan, E.H.Fry, S.C.Saldana, S.E.Brophy, P.L.Richardson, and S.Y.Tetin (2009).
Crystal structure and thermodynamic analysis of diagnostic mAb 106.3 complexed with BNP 5-13 (C10A).
  Proteins, 76, 536-547.
PDB code: 3e8u
19117029 P.A.Galanakis, N.G.Kandias, A.K.Rizos, D.Morikis, E.Krambovitis, and G.A.Spyroulias (2009).
NMR evidence of charge-dependent interaction between various PND V3 and CCR5 N-terminal peptides.
  Biopolymers, 92, 94.  
19515770 R.Pejchal, J.S.Gach, F.M.Brunel, R.M.Cardoso, R.L.Stanfield, P.E.Dawson, D.R.Burton, M.B.Zwick, and I.A.Wilson (2009).
A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.
  J Virol, 83, 8451-8462.
PDB code: 3fn0
18566514 A.K.Dhillon, R.L.Stanfield, M.K.Gorny, C.Williams, S.Zolla-Pazner, and I.A.Wilson (2008).
Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.
  Acta Crystallogr D Biol Crystallogr, 64, 792-802.
PDB code: 3c2a
18068724 C.H.Bell, R.Pantophlet, A.Schiefner, L.A.Cavacini, R.L.Stanfield, D.R.Burton, and I.A.Wilson (2008).
Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.
  J Mol Biol, 375, 969-978.
PDB code: 2qsc
18831795 G.K.Goh, A.K.Dunker, and V.N.Uversky (2008).
Protein intrinsic disorder toolbox for comparative analysis of viral proteins.
  BMC Genomics, 9, S4.  
18366617 J.Gu, and J.S.Liu (2008).
Bayesian biclustering of gene expression data.
  BMC Genomics, 9, S4.  
18473392 N.Krauss, H.Wessner, K.Welfle, H.Welfle, C.Scholz, M.Seifert, K.Zubow, J.Aÿ, M.Hahn, P.Scheerer, A.Skerra, and W.Höhne (2008).
The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
  Proteins, 73, 552-565.
PDB codes: 2or9 2orb
18295345 S.P.Troth, A.D.Dean, and E.A.Hoover (2008).
In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.
  Vet Immunol Immunopathol, 123, 97.  
16946732 F.W.Peyerl, S.Dai, G.A.Murphy, F.Crawford, J.White, P.Marrack, and J.W.Kappler (2007).
Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex.
  Cell Death Differ, 14, 447-452.
PDB code: 2g5b
17418361 R.Pantophlet, R.O.Aguilar-Sino, T.Wrin, L.A.Cavacini, and D.R.Burton (2007).
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.
  Virology, 364, 441-453.  
17411375 T.Cardozo, T.Kimura, S.Philpott, B.Weiser, H.Burger, and S.Zolla-Pazner (2007).
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
  AIDS Res Hum Retroviruses, 23, 415-426.  
16978155 A.M.Andrianov, and V.G.Veresov (2006).
Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches.
  Biochemistry (Mosc), 71, 906-914.  
16378977 C.Pastore, R.Nedellec, A.Ramos, S.Pontow, L.Ratner, and D.E.Mosier (2006).
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
  J Virol, 80, 750-758.  
16361230 T.Watabe, H.Kishino, Y.Okuhara, and Y.Kitazoe (2006).
Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.
  Genetics, 172, 1385-1396.  
15725757 O.Hartley, P.J.Klasse, Q.J.Sattentau, and J.P.Moore (2005).
V3: HIV's switch-hitter.
  AIDS Res Hum Retroviruses, 21, 171-189.  
15723805 R.M.Cardoso, M.B.Zwick, R.L.Stanfield, R.Kunert, J.M.Binley, H.Katinger, D.R.Burton, and I.A.Wilson (2005).
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
  Immunity, 22, 163-173.
PDB code: 1tzg
16094605 V.N.Uversky, C.J.Oldfield, and A.K.Dunker (2005).
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling.
  J Mol Recognit, 18, 343-384.  
14962377 P.D.Kwong (2004).
The 447-52D antibody: hitting HIV-1 where its armor is thickest.
  Structure, 12, 173-174.  
14962380 R.L.Stanfield, M.K.Gorny, C.Williams, S.Zolla-Pazner, and I.A.Wilson (2004).
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
  Structure, 12, 193-204.
PDB code: 1q1j
15103622 S.T.Hsu, and A.M.Bonvin (2004).
Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
  Proteins, 55, 582-593.  
14604823 R.Pantophlet, and D.R.Burton (2003).
Immunofocusing: antigen engineering to promote the induction of HIV-neutralizing antibodies.
  Trends Mol Med, 9, 468-473.  
12121655 J.Ding, A.D.Smith, S.C.Geisler, X.Ma, G.F.Arnold, and E.Arnold (2002).
Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1.
  Structure, 10, 999.
PDB code: 1k5m
12186887 M.K.Gorny, C.Williams, B.Volsky, K.Revesz, S.Cohen, V.R.Polonis, W.J.Honnen, S.C.Kayman, C.Krachmarov, A.Pinter, and S.Zolla-Pazner (2002).
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
  J Virol, 76, 9035-9045.  
11371463 D.Jain, K.J.Kaur, and D.M.Salunke (2001).
Plasticity in protein-peptide recognition: crystal structures of two different peptides bound to concanavalin A.
  Biophys J, 80, 2912-2921.
PDB codes: 1jui 1jyc
11244037 P.Poignard, E.O.Saphire, P.W.Parren, and D.R.Burton (2001).
gp120: Biologic aspects of structural features.
  Annu Rev Immunol, 19, 253-274.  
11322882 W.F.Vranken, F.Fant, M.Budesinsky, and F.A.Borremans (2001).
Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.
  Eur J Biochem, 268, 2620-2628.  
10651813 A.Zvi, V.Tugarinov, G.A.Faiman, A.Horovitz, and J.Anglister (2000).
A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.
  Eur J Biochem, 267, 767-779.  
10628815 J.Su, A.Palm, Y.Wu, S.Sandin, S.Höglund, and A.Vahlne (2000).
Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells.
  AIDS Res Hum Retroviruses, 16, 37-48.  
10644369 P.D.Kwong, R.Wyatt, Q.J.Sattentau, J.Sodroski, and W.A.Hendrickson (2000).
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus.
  J Virol, 74, 1961-1972.  
10801487 V.Tugarinov, A.Zvi, R.Levy, Y.Hayek, S.Matsushita, and J.Anglister (2000).
NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
  Structure, 8, 385-395.
PDB code: 1qnz
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer